5Mg/Vial Thymosin Alpha 1 Muscle Building Peptides CAS 62304-98-7 Medicine Grade

Thymosin α1 Acetate Basic Info

Product Name Thymosin α1 Acetate

Alias : Thymosina1 (ox), Thymalfasin, Thymosina1 (human), Zadaxin, Thymosin α1, Thymosin, Alpha 1, thymosin а1

CAS 62304-98-7

Assay 98.0%

Appearance White Powder

Molecular Formula C129H215N33O55

Molecular Weight 3108.3

Grade Pharmaceutical Grade

Single Impurity (HPLC): 1.0%max

Amino Acid Composition: ±10% of theoretical

Peptide Content (N%): >=80.0%

Water Content(Karl Fischer): <=5.0%

Specific Rotation (20/D): -95.0~-105.0°(c=0.5 1%HAc)

Acetate Content (HPIC): <=15.0%

MS(ESI): Consistent

Mass Balance:95.0~105.0%

Storage: Closed, below 2 ~ 8ºC preservation

Usage : This product is mainly used for the treatment of chronic hepatitis B immune strengthening agent. Thymosin Alpha-1 is being researched for the treatment of Hepatitis B and C, and it is also approved for inclusion with vaccines to boost the immune response in the treatment of other diseases.

Thymosin α1 Acetate Description:

Thymosin α1 is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. Thymosin Alpha-1 is a component of Thymosin Fraction 5 responsible for restoring immune function in animals lacking thymus glands. It was the original peptide synthesized from the Thymosin Fraction 5. Unlike β thymosins, which are genetically and chemically unrelated, Thymosin α1 is produced as a 28-amino acid peptide fragment from a longer, 113-amino acid precursor,prothymosin alpha. Research has shown it to enhance cell-mediated immunity in experimental animals and research subjects.

Thymosin Alpha-1 is being researched for the treatment of Hepatitis B and C, and it is also approved for inclusion with vaccines to boost the immune response in the treatment of other diseases.

Exhibiting a variety of immune regulating properties, thymosin-alpha-1 induces differentiation of murine T-cell precursors and human thymocytes and the terminal differentiation of functionally immature cord blood lymphocytes and induces production of IL-2, high affinity IL-2 receptors, and B-cell growth factors by peripheral blood mononuclear cells. T-helper and cytotoxic/suppressor T-cell populations are targets of thymosin activity. Thymosin-alpha-1 has been shown to increase the efficiency of antigen presentation by macrophages and to be an endogenous modulator of alpha-thrombin activity.

Thymosin α1 Acetate Application:

Thymosin α1 is now approved in 35 under developed or developing countries for the treatment of Hepatitis B and C, and it is also used to boost the immune response in the treatment of other diseases.

Thymosin-alpha-1 has been shown to increase the efficiency of antigen presentation by macrophages and to be an endogenous modulator of alpha-thrombin activity